The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 31, 2017

Filed:

Jul. 12, 2012
Applicants:

Marielle Bouschbacher, Chambolle-Musigny, FR;

Christelle Laurensou, Dijon, FR;

Inventors:

Marielle Bouschbacher, Chambolle-Musigny, FR;

Christelle Laurensou, Dijon, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61L 15/00 (2006.01); A61K 31/7016 (2006.01); A61L 15/44 (2006.01); A61K 9/00 (2006.01); A61K 9/70 (2006.01); A61L 15/28 (2006.01); A61K 31/415 (2006.01); A61K 31/513 (2006.01); A61K 8/34 (2006.01); A61K 8/36 (2006.01); A61K 8/37 (2006.01); A61K 8/60 (2006.01); A61Q 19/00 (2006.01); A61K 8/891 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7016 (2013.01); A61K 8/342 (2013.01); A61K 8/361 (2013.01); A61K 8/37 (2013.01); A61K 8/375 (2013.01); A61K 8/60 (2013.01); A61K 8/891 (2013.01); A61K 9/0014 (2013.01); A61K 9/7015 (2013.01); A61K 31/415 (2013.01); A61K 31/513 (2013.01); A61L 15/28 (2013.01); A61L 15/44 (2013.01); A61Q 19/00 (2013.01); A61L 2300/232 (2013.01); A61L 2300/412 (2013.01);
Abstract

The present invention relates to a compound selected among the synthetic polysulphated oligosaccharides having 1 to 4 ose units and the salts and complexes thereof to be used for the treatment of wounds resulting in pathological scars selected among hypertrophic, retractile or atrophic scars. Said use is preferred in particular in patients that have a predisposition to developing hypertrophic, retractile or atrophic scars. According to a second aspect, the invention also relates to said compound for the use thereof in order to inhibit the differentiation of fibroblasts into myofibroblasts during the cicatrisation of wounds resulting in pathological scars selected among hypertrophic, retractile or atrophic scars.


Find Patent Forward Citations

Loading…